Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CureVac N.V.
  6. News
  7. Summary
    CVAC   NL0015436031

CUREVAC N.V.

(CVAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about CUREVAC N.V.
10/15CureVac Shares Down 12%
DJ
10/13CUREVAC N : EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by Cur..
AQ
10/12Health Care Stocks Falling Despite Moderate Rise Among Biotech Companies
MT
10/12CUREVAC N : Drops COVID-19 Vaccine to Focus on Second-Generation Shot with GlaxoSmithKline
MT
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
PU
10/12CUREVAC N : Forgoes COVID-19 Vaccine Candidate; Stock Slips 15%
MT
10/12CUREVAC N : to Refocus COVID-19 Vaccine Development Efforts to Second-Generation mRNA Cand..
MT
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
PU
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
EQ
10/12PRESS RELEASE : CureVac to Shift Focus of COVID-19 -2-
DJ
10/12PRESS RELEASE : CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generatio..
DJ
10/12CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techno..
CI
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated; Rentschle..
PU
More most relevant news
All news about CUREVAC N.V.
10/15CureVac Shares Down 12%
DJ
10/13CUREVAC N : EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by Cur..
AQ
10/12CLOSE UPDATE : US Stocks Waver Ahead of Earnings, FOMC Minutes; Investors Remain Cautious ..
MT
10/12Health Care Stocks Extending Retreat Ahead of Tuesday Close
MT
10/12Equities Choppy Midday as Clarida Says Fed Would Respond to Rise in Inflation Expectati..
MT
10/12MIDDAY REPORT : US Stocks Choppy as Clarida Says Fed Would Respond to Rise in Inflation Ex..
MT
10/12Health Care Stocks Falling Despite Moderate Rise Among Biotech Companies
MT
10/12CUREVAC N : Drops COVID-19 Vaccine to Focus on Second-Generation Shot with GlaxoSmithKline
MT
10/12Wall Street Set for Cautiously Higher Open, Earnings Season Eyed
MT
10/12Health Care Stocks Edge Higher Premarket Tuesday
MT
More news
News in other languages on CUREVAC N.V.
10/15PRESSESPIEGEL/Unternehmen
10/14Erste Betriebsratswahl bei Curevac
10/14CUREVAC : la pharma abandonne son candidat-vaccin Covid et rejoint ls recherches de GSK
10/14PLANÈTE BOURSE : La revue de presse du jeudi 14 octobre 2021
10/12CLOSE UPDATE : Les actions américaines vacillent avant les résultats et les minutes du FOM..
10/12WALL STREET STOCK EXCHANGE : Verliezen op Wall Street
10/12MÄRKTE USA/Etwas leichter - Anleger vor Berichtssaison in Wartestellung
10/12Les actions du secteur de la santé prolongent leur repli avant la clôture de mardi
10/12WALL STREET STOCK EXCHANGE : Wall Street blijft dichtbij huis
10/12Les actions chutent en milieu de journée alors que Clarida déclare que la Fed réagirait..
More news
Analyst Recommendations on CUREVAC N.V.
07/01CUREVAC : Berenberg reaffirms its Buy rating
MD
06/17CUREVAC N : BofA Securities Downgrades CureVac to Neutral From Buy; Price Target is $50
MT
04/26CUREVAC N : Guggenheim Initiates CureVac at Buy
MT
02/18CUREVAC : Berenberg reaffirms its Buy rating
MD
2020CUREVAC N : Credit Suisse Downgrades CureVac to Underperform from Neutral, Adjusts Price T..
MT
More recommendations
Press releases
10/13CUREVAC N : EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by Cur..
AQ
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
PU
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
PU
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
EQ
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated; Rentschle..
PU
More press releases
Upcoming event on CUREVAC N.V.